While CSF diversion is highly effective at treating hydrocephalus, shunting is unfortunately associated with a very high revision rate. Studies have demonstrated that proximal catheter obstruction is a major cause of failure. A novel proximal access device was developed, and pilot testing was performed in a sheep model of hydrocephalus.
Hydrocephalus was induced in 8 sheep using a cisternal injection of 4 ml of 25% kaolin, and the sheep were randomized to either a standard ventricular catheter or a novel intraparenchymal stent (IPS). Both groups received identical valves and distal catheters. The novel device included a 3D-printed stainless steel port and a 6 × 40–mm covered peripheral vascular stent. Animals were euthanized for signs of hydrocephalus or at a time point of 2 months. MRI was performed to determine ventricular size. Time to failure and Evans indices were compared using the Wilcoxon rank-sum test.
All 4 experimental devices were placed without difficulty into the right lateral ventricle. There was a trend toward longer survival in the experimental group (40 vs 26 days, p = 0.24). Within the IPS group, 3 of the 4 sheep did not experience clinical symptoms of shunt failure and had an average of 37% decrease in Evans index. While 3 of 4 traditional proximal catheters demonstrated debris within the inlet holes, there was no obstructive material found in the IPSs.
An IPS was successfully used to treat hydrocephalus in a sheep model. While statistical significance was not achieved, there were clear benefits to using a stent, including a decreased clog rate and the ability to perform a percutaneous revision. Further testing is needed to ensure efficacy and safety prior to human application.
INCLUDE WHEN CITINGPublished online June 30, 2023; DOI: 10.3171/2023.5.PEDS22545.
DisclosuresThis study used a patented technology that was filed by the University of Rochester. Dr. Stone is an inventor listed on the patent. While there is no direct financial compensation for this work, the University of Rochester and Dr. Stone may financially benefit from this research. Dr. Santangelo has no financial relationship to the patent or licensing company.
DewanMC,RattaniA,MekaryR,et al.Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis.J Neurosurg.2019;130(4):1065–1079.
AoyamaY,KinoshitaY,YokotaA,HamadaT.Neuronal damage in hydrocephalus and its restoration by shunt insertion in experimental hydrocephalus: a study involving the neurofilament-immunostaining method.J Neurosurg.2006;104(5 suppl):332–339.
HanakBW,BonowRH,HarrisCA,BrowdSR.Cerebrospinal fluid shunting complications in children.Pediatr Neurosurg.2017;52(6):381–400.
StoneJJ,WalkerCT,JacobsonM,PhillipsV,SilbersteinHJ.Revision rate of pediatric ventriculoperitoneal shunts after 15 years.J Neurosurg Pediatr.2013;11(1):15–19.
BrowdSR,RagelBT,GottfriedON,KestleJRW.Failure of cerebrospinal fluid shunts: part I: obstruction and mechanical failure.Pediatr Neurol.2006;34(2):83–92.
WeprinBE,SwiftDM.Complications of ventricular shunts.Tech Neurosurg.2001;7(3):224–242.
PaulsenAH,LundarT,LindegaardKF.Pediatric hydrocephalus: 40-year outcomes in 128 hydrocephalic patients treated with shunts during childhood. Assessment of surgical outcome, work participation, and health-related quality of life.J Neurosurg Pediatr.2015;16(6):633–641.
TuliS,DrakeJ,LawlessJ,WiggM,Lamberti-PasculliM.Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus.J Neurosurg.2000;92(1):31–38.
SteinSC,GuoW.Have we made progress in preventing shunt failure? A critical analysis.J Neurosurg Pediatr.2008;1(1):40–47.
HarrisCA,McAllisterJPII.Does drainage hole size influence adhesion on ventricular catheters?Childs Nerv Syst.2011;27(8):1221–1232.
哈基姆S.Observations on the physiopathology of the CSF pulse and prevention of ventricular catheter obstruction in valve shunts.Dev Med Child Neurol Suppl.1969;20(42):48.
BowesAL,King-RobsonJ,DawesWJ,JamesG,AquilinaK.Neuroendoscopic surgery in children: does age at intervention influence safety and efficacy? A single-center experience.J Neurosurg Pediatr.2017;20(4):324–328.
StoneJ,ChandraA.Devices, systems and methods for diverting fluid trapped in a solid organ.US patent 20140276342A1..September 18, 2014.
JohnstonMG,Del BigioMR,DrakeJM,ArmstrongD,Di CurzioDL,BertrandJ.Pre- and post-shunting observations in adult sheep with kaolin-induced hydrocephalus.Fluids Barriers CNS.2013;10(1):24.
SynekV,ReubenJR,Du BoulayGH.Comparing Evans’ index and computerized axial tomography in assessing relationship of ventricular size to brain size.Neurology.1976;26(3):231–233.
SchoenerWF,ReparonC,VerheggenR,MarkakisE.评估合规analysi分流失败的s and inspection of shunt valves and shunt materials, using microscopic or scanning electron microscopic techniques. In:MatsumotoS,TamakiN, eds.Hydrocephalus.SpringerJapan;1991:452-472.
MwachakaPM,ObonyoNG,MutisoBK,RanketiS,Mwang’ombeN.Ventriculoperitoneal shunt complications: a three-year retrospective study in a Kenyan national teaching and referral hospital.Pediatr Neurosurg.2010;46(1):1–5.
PatwardhanRV,NandaA.Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment.开云体育app官方网站下载入口.2005;56(1):139–145.
LeHankaA,PiattJ.Readmission and reoperation for hydrocephalus: a population-based analysis across the spectrum of age.J Neurosurg.2020;134(3):1210–1217.
SimonTD,Riva-CambrinJ,SrivastavaR,BrattonSL,DeanJM,KestleJR.Hospital care for children with hydrocephalus in the United States: utilization, charges, comorbidities, and deaths.J Neurosurg Pediatr.2008;1(2):131–137.
SunderlandGJ,JenkinsonMD,ConroyEJ,GambleC,MallucciCL.Neurosurgical CSF diversion in idiopathic intracranial hypertension: a narrative review.Life (Basel).2021;11(5):393.
LylykP,LylykI,BleiseC,et al.First-in-human endovascular treatment of hydrocephalus with a miniature biomimetic transdural shunt.J Neurointerv Surg.2022;14(5):495–499.
KulkarniAV,DrakeJM,KestleJRW,MallucciCL,SgourosS,ConstantiniS.Predicting who will benefit from endoscopic third ventriculostomy compared with shunt insertion in childhood hydrocephalus using the ETV Success Score.J Neurosurg Pediatr.2010;6(4):310–315.
StoneSSD,WarfBC.Combined endoscopic third ventriculostomy and choroid plexus cauterization as primary treatment for infant hydrocephalus: a prospective North American series.J Neurosurg Pediatr.2014;14(5):439–446.
WarfBC,TracyS,MugambaJ.Long-term outcome for endoscopic third ventriculostomy alone or in combination with choroid plexus cauterization for congenital aqueductal stenosis in African infants.J Neurosurg Pediatr.2012;10(2):108–111.
GrandW,LeonardoJ,ChamczukAJ,KorusAJ.内镜第三ventriculostomy in 250 adults with hydrocephalus: patient selection, outcomes, and complications.开云体育app官方网站下载入口.2016;78(1):109–119.
Riva-CambrinJ,KestleJRW,RozzelleCJ,et al.Predictors of success for combined endoscopic third ventriculostomy and choroid plexus cauterization in a North American setting: a Hydrocephalus Clinical Research Network study.J Neurosurg Pediatr.2019;24(2):128–138.
EtusV,CeylanS.Success of endoscopic third ventriculostomy in children less than 2 years of age.Neurosurg Rev.2005;28(4):284–288.
WuY,GreenNL,WrenschMR,ZhaoS,GuptaN.Ventriculoperitoneal shunt complications in California: 1990 to 2000.开云体育app官方网站下载入口.2007;61(3):557–563.
PaffM,Alexandru-AbramsD,MuhonenM,LoudonW.Ventriculoperitoneal shunt complications: a review.Interdiscip Neurosurg.2018;13:66–70.
Amin-HanjaniS,PirlWF,FeskeSK,BlackPM.脑积水和cereb的障碍rospinal fluid flow. In:SamuelsMA,FeskeSK, eds.Office Practice of Neurology.2nd ed.Churchill Livingstone;2003:159-167.
MoriE,IshikawaM,KatoT,et al.Guidelines for management of idiopathic normal pressure hydrocephalus: second edition.Neurol Med Chir (Tokyo).2012;52(11):775–809.
RelkinN,MarmarouA,KlingeP,BergsneiderM,BlackPM.Diagnosing idiopathic normal-pressure hydrocephalus.开云体育app官方网站下载入口.2005;57(3 suppl):S4-S16,ii-v.
TomaAK,HollE,KitchenND,WatkinsLD.Evans’ index revisited: the need for an alternative in normal pressure hydrocephalus.开云体育app官方网站下载入口.2011;68(4):939–944.
SchenkerP,StieglitzLH,SickB,StienenMN,RegliL,SarntheinJ.Patients with a normal pressure hydrocephalus shunt have fewer complications than do patients with other shunts.World Neurosurg.2018;110:e249–e257.
ParkJH,ParkYS,SukJS,et al.Cerebrospinal fluid pathways from cisterns to ventricles in N-butyl cyanoacrylate-induced hydrocephalic rats.J Neurosurg Pediatr.2011;8(6):640–646.
AlcázarL,AlfaroR,TamaritM,et al.Delayed intracerebral hemorrhage after ventriculoperitoneal shunt insertion.Case report and literature review. Neurocirugia (Astur).2007;18(2):128–133.
PalmieriA,PasquiniU,MenichelliF,SalvoliniU.Cerebral damage following ventricular shunt for infantile hydrocephalus evaluated by computed tomography.Neuroradiology.1981;21(1):33–35.
TominagaJ,ShimodaM,OdaS,KumasakaA,YamazakiK,TsuganeR.MRimaging findings after ventricular puncture in patients with SAH.Acta Neurochir (Wien).2001;143(11):1133–1140.
MüllerA,MouldWA,FreemanWD,et al.The incidence of catheter tract hemorrhage and catheter placement accuracy in the CLEAR III trial.Neurocrit Care.2018;29(1):23–32.
BerlisA,VesperJ,OstertagC.Stent placement for intracranial cysts by combined stereotactic/endoscopic surgery.开云体育app官方网站下载入口.2006;59(4 suppl 2):ONS474–ONS480.
AVMA Guidelines for the Euthanasia of Animals: 2013 Edition.American Veterinary Medical Association;2013.Accessed June 8, 2023.https://www.in.gov/boah/files/AVMA_Euthanasia_Guidelines.pdf
NotarianniC,VannemreddyP,CalditoG,et al.Congenital hydrocephalus and ventriculoperitoneal shunts: influence of etiology and programmable shunts on revisions.J Neurosurg Pediatr.2009;4(6):547–52.
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 451 | 451 | 111 |
Full Text Views | 53 | 53 | 9 |
PDF Downloads | 69 | 69 | 12 |
EPUB Downloads | 0 | 0 | 0 |